Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Biotelemetry Inc (BEAT)

$35.61 2.90 (7.53%)

11:18 EDT BEAT Stock Quote Delayed 20 Minutes

Volume:

Previous Close $38.51

Market Cap 1.17B

PE Ratio -96.24

EPS -0.37

Volume (Avg. Vol.) 183,089

Day's Range 31.24 - 37.68

52-Week Range 27.35 - 63.24

Dividend & Yield N/A (N/A)

BEAT Stock Predictions, Articles, and Biotelemetry Inc News

From InvestorPlace
From the Web

10 Triple-A Stocks to Buy for the Rest of 2018

By Louis Navellier, Editor, Growth Investor Nov 21, 2018

Here are some triple-a stocks to buy that are primed to start the new year going strong.

7 Market-Beating Stocks to Buy to Weather a Trade War

By Louis Navellier, Editor, Growth Investor Sep 21, 2018

As potential impacts from the trade war with China loom, these stocks to buy are far more prepared to weather the storm.

4 Top Stocks to Buy on Blockbuster Earnings Growth

By Zacks Investment Research Jul 31, 2018

We shortlist four solid stocks that have striking earnings growth and positive estimate revisions. Compare Brokers....

10 Small-Caps Leading the Market Rebound

By Anthony Mirhaydari, InvestorPlace Market Strategist Jul 10, 2018

The tone of trade is a definitive "risk on" with equities rallying, Treasury bonds pulling back and overall market breadth strong. The action in small-cap stocks has been particularly impressive, with the Russell 2000 set to cap a five-day winning streak.

3 Heart Disease Focused Stocks to Buy Ahead of World Heart Day

By Zacks Investment Research Sep 27, 2017

With World Heart Day coming up, here is a look at some well-positioned stocks including BioTelemetry (BEAT) in this segment of the market.

Interesting BEAT Put And Call Options For November 20th

From Market News Video Apr 1, 2020

Investors in BioTelemetry Inc (BEAT) saw new options begin trading this week, for the November 20th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 233 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

How Does BioTelemetry’s (NASDAQ:BEAT) P/E Compare To Its Industry, After The Share Price Drop?

From Simply Wall St Mar 20, 2020

To the annoyance of some shareholders, BioTelemetry (NASDAQ:BEAT) shares are down a considerable 41% in the last month. That drop has capped off a tough year for shareholders, with the<div><a class="permalink" href="https://simplywall.st/stocks/us/healthcare/nasdaq-beat/biotelemetry/news/how-does-biotelemetrys-nasdaqbeat-p-e-compare-to-its-industry-after-the-share-price-drop/">Read More...</a></div>

We Think BioTelemetry (NASDAQ:BEAT) Can Stay On Top Of Its Debt

From Simply Wall St Mar 19, 2020

Legendary fund manager Li Lu (who Charlie Munger backed) once said, ‘The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of<div><a class="permalink" href="https://simplywall.st/stocks/us/healthcare/nasdaq-beat/biotelemetry/news/we-think-biotelemetry-nasdaqbeat-can-stay-on-top-of-its-debt/">Read More...</a></div>

The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates

From Benzinga Mar 18, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) BioNTech SE – ADR...

The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO

From Benzinga Mar 12, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) Bicycle Therapeutics...

What Does BioTelemetry, Inc.’s (NASDAQ:BEAT) P/E Ratio Tell You?

From Simply Wall St Mar 6, 2020

The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We’ll show how you can use BioTelemetry, Inc.’s (NASDAQ:BEAT) P/E ratio to<div><a class="permalink" href="https://simplywall.st/stocks/us/healthcare/nasdaq-beat/biotelemetry/news/what-does-biotelemetry-inc-s-nasdaqbeat-p-e-ratio-tell-you/">Read More...</a></div>

Navellier Ratings

Powered by Portfolio Grader

Total Grade

D

Sell